|
CEP170L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.703000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.177300E-03 |
| Normal-vs-Stage2 |
6.083700E-02 |
| Normal-vs-Stage3 |
2.258000E-02 |
| Normal-vs-Stage4 |
7.779100E-03 |
| Stage1-vs-Stage2 |
5.108600E-01 |
| Stage1-vs-Stage3 |
6.759600E-01 |
| Stage1-vs-Stage4 |
7.194600E-01 |
| Stage2-vs-Stage3 |
7.791600E-01 |
| Stage2-vs-Stage4 |
4.212600E-01 |
| Stage3-vs-Stage4 |
5.147000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.624100E-03 |
| Normal-vs-AfricanAmerican |
5.676000E-02 |
| Normal-vs-Asian |
1.434500E-02 |
| Caucasian-vs-AfricanAmerican |
7.911200E-01 |
| Caucasian-vs-Asian |
9.957000E-01 |
| AfricanAmerican-vs-Asian |
7.815400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.219910E-02 |
| Normal-vs-Female |
9.381100E-03 |
| Male-vs-Female |
9.258200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.415900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.645600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.523940E-02 |
| Normal-vs-Age(81-100Yrs) |
3.810300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.664600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.661600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.200800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.800400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.203400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.075200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.055200E-01 |
| Classical-VS-Follicular |
1.617770E-01 |
| Classical-VS-Other |
1.435770E-02 |
| Classical-VS-Normal |
2.146400E-02 |
| Tall-VS-Follicular |
6.430400E-01 |
| Tall-VS-Other |
1.278570E-01 |
| Tall-VS-Normal |
4.381500E-02 |
| Follicular-VS-Other |
1.201160E-01 |
| Follicular-VS-Normal |
4.615300E-03 |
| Other-VS-Normal |
4.152400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.319800E-03 |
| Normal-vs-N1 |
5.185700E-02 |
| N0-vs-N1 |
1.657650E-01 |
|
|
